Latest Articles
Immunotherapy Continues to Redefine Treamtent Considerations in Advanced/Recurrent Endometrial Cancer - OncLive
Immunotherapy Continues to Redefine Treamtent Considerations in Advanced/Recurrent Endometrial Cancer OncLive
Published: March 6, 2025, 2:32 p.m.
Establishment and validation of a prognostic nomogram for overall survival in type II endometrial carcinoma patients - Nature.com
Establishment and validation of a prognostic nomogram for overall survival in type II endometrial carcinoma patients Nature.com
Published: March 6, 2025, 6:11 a.m.
The Prognostic Value of Maximum Standardized Uptake Value (SUVmax) of 18F-FDG PET/CT for Risk Stratification and Outcome Prediction in Endometrial Cancer: A Retrospective Analysis - Cureus
The Prognostic Value of Maximum Standardized Uptake Value (SUVmax) of 18F-FDG PET/CT for Risk Stratification and Outcome Prediction in Endometrial Cancer: A Retrospective Analysis Cureus
Published: March 6, 2025, 1:45 a.m.
The impact of intrauterine adhesions on endometrial receptivity in patients undergoing in vitro fertilization-embryo transfer - Frontiers
The impact of intrauterine adhesions on endometrial receptivity in patients undergoing in vitro fertilization-embryo transfer Frontiers
Published: March 5, 2025, 9:36 p.m.
Dr Wagar on Lenvatinib Plus Pembrolizumab vs Chemo in First-Line Advanced Endometrial Cancer - OncLive
Dr Wagar on Lenvatinib Plus Pembrolizumab vs Chemo in First-Line Advanced Endometrial Cancer OncLive
Published: March 5, 2025, 8:17 p.m.
ASCO Reading Room | Gita Suneja on Shorter Vaginal Radiation for Endometrial Cancer - Medpage Today
ASCO Reading Room | Gita Suneja on Shorter Vaginal Radiation for Endometrial Cancer Medpage Today
Published: March 5, 2025, 4:47 p.m.
Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial - Nature.com
Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial Nature.com
Published: March 5, 2025, 11:04 a.m.
Short-Course Vaginal Cuff Brachytherapy Feasible for Early-Stage Endometrial Cancer - Oncology Nurse Advisor
Short-Course Vaginal Cuff Brachytherapy Feasible for Early-Stage Endometrial Cancer Oncology Nurse Advisor
Published: March 5, 2025, 5 a.m.
Newly discovered biomarkers could improve endometrial cancer treatment - Medical Xpress
Newly discovered biomarkers could improve endometrial cancer treatment Medical Xpress
Published: March 4, 2025, 8:55 p.m.
miR-21 regulates autophagy and apoptosis of ectopic endometrial stromal cells of adenomyosis via PI3K/ AKT/ mTOR pathway - Nature.com
miR-21 regulates autophagy and apoptosis of ectopic endometrial stromal cells of adenomyosis via PI3K/ AKT/ mTOR pathway Nature.com
Published: March 4, 2025, 5:55 p.m.
Link copied to clipboard!